FDA.reportPublic FDA data

24 HR Namenda 14 MG Extended Release Oral Capsule

RxCUI
996597
RxNorm name
24 HR Namenda 14 MG Extended Release Oral Capsule
Display name
24 HR Namenda 14 MG Extended Release Oral Capsule
Full name
24 HR Namenda 14 MG Extended Release Oral Capsule
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:50

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
1fa2b7bc-94e5-4566-a7c5-419f8fd393a7Namenda XR 14 MG 24HR Extended Release Oral Capsule [PSN] · 24 HR memantine hydrochloride 14 MG Extended Release Oral Capsule [Namenda] [SBD] · 24 HR Namenda 14 MG Extended Release Oral Capsule [SY] · Namenda XR 14 MG 24 HR Extended Release Oral Capsule [SY]46These highlights do not include all the information needed to use NAMENDA XR capsules safely and effectively. See full prescribing information for NAMENDA XR capsules. NAMENDA XR (memantine hydrochloride) extended release capsules, for oral use Initial U.S. Approval: 200320171228